Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.     PRESS RELEASE INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), a licensed producer under the Access to Cannabis for Medical Purposes
Complete Reading

Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update   FOREX INVESSTORS  PRESS RELEASE  Acreage Pharms Ltd   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its licensed production facility under the Access to Cannabis for Medical Purposes
Complete Reading

Invictus MD Announces Inclusion on Horizons Marijuana Life Sciences Index ETF     BUZ INVESTORS PRESS RELEASE  Invictus MD Announces Inclusion  INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce its inclusion in the Horizon Medical Marijuana Life Sciences ETF (TSX:HMMJ) (“HMMJ ETF”), which is
Complete Reading

Invictus MD’s Executive Chairman Provides a Corporate Update BUZ INVESTORS  Corporate Update  INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) Canada’s Cannabis Company, is pleased to provide a corporate update on the back of its recently closed bought deal financing, and reprises its vision to expand and solidify its
Complete Reading

Invictus MD Closes $25,008,750 Bought Deal Private Placement Private Placement BUZ INVESTORS PRESS RELEASE Private Placement   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has closed its previously announced bought deal private placement (the “Offering”), with Canaccord Genuity Corp., Eventus Capital
Complete Reading

Create Account



Log In Your Account